Cargando…
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?
Autores principales: | Hamdan, Diaddin, Marisa, Laetitia, Tlemsani, Camille, Angeli, Eurydice, Soussan, Michael, Derive, Nicolas, Laurent-Puig, Pierre, Bousquet, Guilhem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309575/ https://www.ncbi.nlm.nih.gov/pubmed/36848605 http://dx.doi.org/10.1200/PO.22.00582 |
Ejemplares similares
-
Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
por: File, Danielle M., et al.
Publicado: (2020) -
A Boom in Nanotechnologies for a High Level of Precision Medicine
por: Angeli, Eurydice, et al.
Publicado: (2023) -
Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications
por: Nguyen, Thuy Thi, et al.
Publicado: (2023) -
Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier
por: Angeli, Eurydice, et al.
Publicado: (2021) -
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response
por: Valiakhmetova, Andge, et al.
Publicado: (2019)